These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 8686548)
21. Phase I evaluation of preirradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomas. Rajkumar SV; Buckner JC; Schomberg PJ; Pitot HC; Ingle JN; Cascino TL Neurosurgery; 1999 Jan; 44(1):67-73. PubMed ID: 9894965 [TBL] [Abstract][Full Text] [Related]
22. Treatment of recurrent gliomas with 1,3-bis(2-chloroethyl)-1-nitrosourea and alpha-difluoromethylornithine. Prados M; Rodriguez L; Chamberlain M; Silver P; Levin V Neurosurgery; 1989 Jun; 24(6):806-9. PubMed ID: 2546093 [TBL] [Abstract][Full Text] [Related]
24. Combined intra-arterial and systemic chemotherapy for recurrent malignant brain tumors. Watne K; Hannisdal E; Nome O; Hager B; Hirschberg H Neurosurgery; 1992 Feb; 30(2):223-7. PubMed ID: 1312230 [TBL] [Abstract][Full Text] [Related]
25. [Treatment of supratentorial glioma with intracarotid cisplatin and intravenous carmustine]. Rebollo J; Martín-Algarra S; Bilbao I; Zubieta JL; Calvo FA; de Castro P; Pastor MA; Viteri C; Martínez Lage JM Neurologia; 1990; 5(7):228-32. PubMed ID: 1963067 [TBL] [Abstract][Full Text] [Related]
26. Selenium in the treatment of patients with brain gliomas. A pilot study. Philipov P; Tzatchev K Zentralbl Neurochir; 1990; 51(3):145-6. PubMed ID: 1965466 [TBL] [Abstract][Full Text] [Related]
27. BCNU-DBD (Dibromodulcitol) chemotherapy of recurrent supratentorial anaplastic astrocytomas and glioblastomas. Vitanovics D; Sipos L; Afra D Neoplasma; 2002; 49(5):342-5. PubMed ID: 12458335 [TBL] [Abstract][Full Text] [Related]
28. Phase II trial of radiotherapy after hyperbaric oxygenation with multiagent chemotherapy (procarbazine, nimustine, and vincristine) for high-grade gliomas: long-term results. Ogawa K; Ishiuchi S; Inoue O; Yoshii Y; Saito A; Watanabe T; Iraha S; Toita T; Kakinohana Y; Ariga T; Kasuya G; Murayama S Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):732-8. PubMed ID: 21420247 [TBL] [Abstract][Full Text] [Related]
29. Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy. Reulen HJ; Poepperl G; Goetz C; Gildehaus FJ; Schmidt M; Tatsch K; Pietsch T; Kraus T; Rachinger W J Neurosurg; 2015 Sep; 123(3):760-70. PubMed ID: 26140493 [TBL] [Abstract][Full Text] [Related]
30. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study. Chang CH; Horton J; Schoenfeld D; Salazer O; Perez-Tamayo R; Kramer S; Weinstein A; Nelson JS; Tsukada Y Cancer; 1983 Sep; 52(6):997-1007. PubMed ID: 6349785 [TBL] [Abstract][Full Text] [Related]
31. High-dose carmustine with autologous bone marrow transplantation for the adjuvant treatment of high-grade gliomas of the central nervous system. Wolff SN; Phillips GL; Herzig GP Cancer Treat Rep; 1987 Feb; 71(2):183-5. PubMed ID: 3026626 [TBL] [Abstract][Full Text] [Related]
32. A retrospective study of the value of chemotherapy as adjuvant therapy to surgery and radiotherapy in grade 3 and 4 gliomas. Gundersen S; Lote K; Watne K Eur J Cancer; 1998 Sep; 34(10):1565-9. PubMed ID: 9893629 [TBL] [Abstract][Full Text] [Related]
33. [Chemotherapy of recurrent supratentorial malignant gliomas (phase II study)]. Afra D; Sipos L; Vitanovics D Ideggyogy Sz; 2002 Jan; 55(1-2):38-44. PubMed ID: 12122942 [TBL] [Abstract][Full Text] [Related]
34. Preirradiation chemotherapy of supratentorial malignant primary brain tumors with intracarotid cis-platinum (CDDP) and i.v. BCNU. A phase II trial. Recht L; Fram RJ; Strauss G; Fitzgerald TJ; Liepman M; Lew R; Kadish S; Sherman D; Wilson J; Greenberger J Am J Clin Oncol; 1990 Apr; 13(2):125-31. PubMed ID: 2156417 [TBL] [Abstract][Full Text] [Related]
35. Phase 1 study of 28-day, low-dose temozolomide and BCNU in the treatment of malignant gliomas after radiation therapy. Raizer JJ; Malkin MG; Kleber M; Abrey LE Neuro Oncol; 2004 Jul; 6(3):247-52. PubMed ID: 15279717 [TBL] [Abstract][Full Text] [Related]
36. Chemotherapy in low-grade astrocytoma management. Castello MA; Schiavetti A; Varrasso G; Clerico A; Cappelli C Childs Nerv Syst; 1998; 14(1-2):6-9. PubMed ID: 9548332 [TBL] [Abstract][Full Text] [Related]
37. Advantages and Disadvantages of Combined Chemotherapy with Carmustine Wafer and Bevacizumab in Patients with Newly Diagnosed Glioblastoma: A Single-Institutional Experience. Akiyama Y; Kimura Y; Enatsu R; Mikami T; Wanibuchi M; Mikuni N World Neurosurg; 2018 May; 113():e508-e514. PubMed ID: 29476996 [TBL] [Abstract][Full Text] [Related]
38. High-dose BCNU followed by autologous hematopoietic stem cell transplantation in supratentorial high-grade malignant gliomas: a retrospective analysis of 114 patients. Durando X; Lemaire JJ; Tortochaux J; Van-Praagh I; Kwiatkowski F; Vincent C; Bailly C; Verrelle P; Irthum B; Chazal J; Bay JO Bone Marrow Transplant; 2003 Apr; 31(7):559-64. PubMed ID: 12692621 [TBL] [Abstract][Full Text] [Related]
39. Combined stereotactic split-course fractionated gamma knife radiosurgery and conventional radiation therapy for unfavorable gliomas: a phase I study. Regine WF; Patchell RA; Strottmann JM; Meigooni A; Sanders M; Young B J Neurosurg; 2000 Dec; 93 Suppl 3():37-41. PubMed ID: 11143260 [TBL] [Abstract][Full Text] [Related]
40. Phase II study of accelerated fractionation radiation therapy with carboplatin followed by PCV chemotherapy for the treatment of anaplastic gliomas. Levin VA; Yung WK; Bruner J; Kyritsis A; Leeds N; Gleason MJ; Hess KR; Meyers CA; Ictech SA; Chang E; Maor MH Int J Radiat Oncol Biol Phys; 2002 May; 53(1):58-66. PubMed ID: 12007942 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]